Financials data is unavailable for this security.
View more
Year on year GoodRx Holdings Inc had relatively flat revenues (766.55m to 750.27m), though the company grew net income from a loss of 32.83m to a smaller loss of 8.87m. A reduction in the selling, general and administrative costs as a percentage of sales from 63.58% to 61.99% was a component in the net income growth despite flat revenues.
| Gross margin | 93.52% |
|---|---|
| Net profit margin | -2.05% |
| Operating margin | 3.12% |
| Return on assets | -1.06% |
|---|---|
| Return on equity | -2.06% |
| Return on investment | -1.15% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at GoodRx Holdings Inc fell by 84.87m. However, the company earned 138.29m from its operations for a Cash Flow Margin of 18.43%. In addition the company used 55.77m on investing activities and also paid 167.40m in financing cash flows.
| Cash flow per share | 0.1987 |
|---|---|
| Price/Cash flow per share | 21.01 |
| Book value per share | 1.83 |
|---|---|
| Tangible book value per share | 0.2934 |
More ▼
Balance sheet in USDView more
| Current ratio | 5.48 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.7055 |
|---|---|
| Total debt/total capital | 0.4137 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 72.82%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -208.72 |
